TrialJournal of clinical pharmacology2026

Dose Optimization of BIIB107, an Anti-Alpha-4 Integrin Monoclonal Antibody, Through Population Pharmacokinetic and Pharmacodynamic Modeling.

Marie Toukam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.